Celecoxib

Nonsteroidal Anti-inflammatory Drug

Brands

Celebrex
Consensi

Celecoxib Oral Tablet

DosageBrandImage
amlodipine 10 MG / celecoxib 200 MG Oral TabletGeneric
amlodipine 10 MG / celecoxib 200 MG Oral Tablet [Consensi]Generic
amlodipine 2.5 MG / celecoxib 200 MG Oral TabletGeneric
amlodipine 2.5 MG / celecoxib 200 MG Oral Tablet [Consensi]Generic
amlodipine 5 MG / celecoxib 200 MG Oral TabletGeneric
amlodipine 5 MG / celecoxib 200 MG Oral Tablet [Consensi]Generic

Celecoxib Oral Capsule

DosageBrandImage
celecoxib 100 MG Oral CapsuleGenericWHITE, BLUE CAPSULE 7767;100 celecoxib 100 MG Oral Capsule
celecoxib 100 MG Oral Capsule [Celebrex]GenericWHITE, BLUE CAPSULE 7767;100 celecoxib 100 MG Oral Capsule [Celebrex]
celecoxib 200 MG Oral CapsuleGenericWHITE, YELLOW CAPSULE 7767;200 celecoxib 200 MG Oral Capsule
celecoxib 200 MG Oral Capsule [Celebrex]GenericWHITE, YELLOW CAPSULE 7767;200 celecoxib 200 MG Oral Capsule [Celebrex]
celecoxib 400 MG Oral CapsuleGenericGREEN CAPSULE TEVA;7170 celecoxib 400 MG Oral Capsule
celecoxib 400 MG Oral Capsule [Celebrex]Generic
celecoxib 50 MG Oral CapsuleGenericWHITE, ORANGE CAPSULE TEVA;7306 celecoxib 50 MG Oral Capsule
celecoxib 50 MG Oral Capsule [Celebrex]Generic

Celecoxib desired effects:

  • Decreased Prostaglandin Production

Celecoxib drug classes:

  • Nonsteroidal Anti-inflammatory Drug

Celecoxib pharmacologic actions:

  • Cyclooxygenase 2 Inhibitors
  • Anti-Inflammatory Agents, Non-Steroidal

Celecoxib mechanism of action:

  • Cyclooxygenase Inhibitors
  • Cyclooxygenase 2 Inhibitors
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Questions? Call or text: 859-651-7603

LegitScript approved
Copyright © Treatable 2023
Last updated: 1/29/2025, 6:08:58 PM